-
-
Toggle navigation
Frontiers reaches 6.4 on Journal Impact Factors
in Oncology |
|
Submit your manuscript
Scope
It is devoted to the publication of high quality research concerning all aspects of cancer cell biology and cancer biochemistry. The aim of the Specialty Section is to cover the entire area devoted to the molecular and cellular characterization of cancer cells, irrespective of the precise type of malignancy. Molecular and Cellular Oncology has a particular interest in the mechanistic characterization of oncogenes and tumor suppressor genes. Cancers are distinguished by self-sufficiency in growth signals, insensitivity to antigrowth signals, invalidation of cell death programs, limitless replicative potential, sustained angiogenesis, tissue invasion and metastasis, avoidance of immunosurveillance, anabolic metabolism and suppressed autophagy. As a result, Molecular and Cellular Oncology is interested in publishing papers dealing with the cellular and biochemical alterations that explain these hallmarks of cancer. It should be noted that solid tumors are composed of parenchymatous and stromal elements that form a sort of micro-ecosystem. Papers dealing with the crosstalk between cancer cells and stromal cells, including immune effectors are welcome. Progress in cancer research has been accelerated by "omics" technologies (including genomics, proteomics, metabolomics etc.), and articles from this area will be published, especially if they reveal new cellular or biochemical aspects of cancer biology. Thus, Molecular and Cellular Oncology will promote the implementation and utilization of systems biology (or integrated biology) for establishing a continuum between fundamental, translational and clinical research.Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
Molecular and Cellular Oncology welcomes submissions of the following article types: Book Review, Brief Research Report, Case Report, Clinical Trial, Correction, Data Report, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Molecular and Cellular Oncology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Molecular and Cellular Oncology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Cell and Developmental Biology and Oncology.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01